Skip to main content
SpringerLink
Log in

Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting

  • Letter to the Editor
  • Published:
European Journal of Nuclear Medicine and Molecular Imaging Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Reference

  1. Guggenberg EV, Mikolajczak R, Janota B, Riccabona G, Decristoforo C. Radiopharmaceutical development of a freeze-dried kit formulation for the preparation of [99mTc-EDDA-HYNIC-D-Phe1,Tyr3]-octreotide, a somatostatin analog for tumor diagnosis. J Pharm Sci. 2004;93(10):2497–506.

    Article  PubMed  Google Scholar 

Download references

Conflicts of interest

None.

Author information

Authors and Affiliations

  1. Radiation Medicine Centre (B.A.R.C), Tata Memorial Centre Annexe, Jerbai Wadia Road, Parel, Mumbai, 400012, India

    Sandip Basu, Purushottam Kand & Hemant Shimpi

  2. Radiopharmaceutical Division, Bhabha Atomic Research Centre, Trombay, Mumbai, 400094, India

    Madhav Mallia & Aruna Korde

Authors
  1. Sandip Basu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Purushottam Kand
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Madhav Mallia
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Aruna Korde
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hemant Shimpi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sandip Basu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Basu, S., Kand, P., Mallia, M. et al. Gratifying clinical experience with an indigenously formulated single-vial lyophilized HYNIC-TOC kit at the radiopharmaceutical division of BARC: a pivotal boost for building up a peptide receptor radionuclide therapy programme in an Indian setting. Eur J Nucl Med Mol Imaging 40, 1622–1624 (2013). https://doi.org/10.1007/s00259-013-2501-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00259-013-2501-0

Keywords

Search

Navigation